KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Gross Margin (2016 - 2025)

Elevance Health (ELV) has disclosed Gross Margin for 17 consecutive years, with 88.8% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 6252.0% to 88.8% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 74.03% through Dec 2025, up 1817.0% year-over-year, with the annual reading at 89.28% for FY2025, 6135.0% up from the prior year.
  • Gross Margin for Q4 2025 was 88.8% at Elevance Health, down from 89.39% in the prior quarter.
  • The five-year high for Gross Margin was 91.85% in Q3 2021, with the low at 156.68% in Q4 2023.
  • Average Gross Margin over 5 years is 47.91%, with a median of 53.28% recorded in 2022.
  • The sharpest move saw Gross Margin crashed -23467bps in 2023, then skyrocketed 18296bps in 2024.
  • Over 5 years, Gross Margin stood at 90.02% in 2021, then decreased by -13bps to 77.99% in 2022, then crashed by -301bps to 156.68% in 2023, then skyrocketed by 117bps to 26.28% in 2024, then skyrocketed by 238bps to 88.8% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 88.8%, 89.39%, and 89.29% for Q4 2025, Q3 2025, and Q2 2025 respectively.